Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis.
Saved in:
| Title: | Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis. |
|---|---|
| Authors: | Annunziata, Giuseppe1 (AUTHOR), Scala, Emanuele2 (AUTHOR) emanuele.scala@idi.it, Mercurio, Laura2,3 (AUTHOR), Sanna, Luca2,4 (AUTHOR), Dattolo, Anna2,5 (AUTHOR), Pagnanelli, Gianluca3,6 (AUTHOR), Lolli, Maria Grazia2,7 (AUTHOR), Belli, Roberta1,2 (AUTHOR), Moretta, Gaia2,3 (AUTHOR), Savastano, Silvia3,4,5 (AUTHOR), Muscogiuri, Giovanna4,5,6 (AUTHOR), Maisto, Maria5,7 (AUTHOR), Ciampaglia, Roberto6,7 (AUTHOR), Piccolo, Vincenzo7 (AUTHOR), Tenore, Gian Carlo7 (AUTHOR), Albanesi, Cristina2 (AUTHOR), Madonna, Stefania2 (AUTHOR), Barrea, Luigi1 (AUTHOR) |
| Source: | Life (2075-1729). Nov2025, Vol. 15 Issue 11, p1703. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20751729 |
|---|---|
| DOI: | 10.3390/life15111703 |
